Reports by quarter

Reports submitted in 2026-Q2 · page 23

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 98.90 % area, n=1009. Read the 2026-Q2 state-of-the-index report →

1,009 records26 pagesmedian on this page 98.96 %updated 30 Jul 2026

Report	Compound	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-041465	SS-31 (Elamipretide)	QYB	QYB-2512-H5402	PeptideMeter	2026-Q2	99.35	5.44	—	Supplier-supplied	0	PASS
AX-2026-041369	Semaglutide	WWB	WWB-2512-T3671	Medutest	2026-Q2	99.57	3.34	—	Supplier-supplied	1	MARGINAL
AX-2026-041294	Semaglutide	WWB	WWB-2603-N3120	VendorInvestigate	2026-Q2	98.98	6.20	—	Buyer-sourced	3	FAIL
AX-2026-043458	BPC-157	WXT	WXT-2602-W4680	PeptideMeter	2026-Q2	97.85	5.19	—	Supplier-supplied	2	FAIL
AX-2026-043121	Mazdutide	SSA	SSA-2605-G6781	Medutest	2026-Q2	98.79	2.52	—	Supplier-supplied	1	MARGINAL
AX-2026-042698	Retatrutide	GGPeps	GGPE-2512-D9394	Janoshik	2026-Q2	98.58	3.35	—	Supplier-supplied	1	MARGINAL
AX-2026-042586	SLU-PP-332	GGPeps	GGPE-2511-R8569	Medutest	2026-Q2	98.35	4.78	101.6	Buyer-sourced	1	MARGINAL
AX-2026-042519	Liraglutide	ERP	ERP-2601-P6802	Janoshik	2026-Q2	98.88	4.41	95.2	Supplier-supplied	1	MARGINAL
AX-2026-042104	Retatrutide	TFC	TFC-2512-G7985	Kestrel	2026-Q2	99.49	1.97	95.1	Supplier-supplied	1	MARGINAL
AX-2026-042087	PT-141 (Bremelanotide)	TFC	TFC-2512-V7681	Janoshik	2026-Q2	99.25	3.16	102.8	Supplier-supplied	0	PASS
AX-2026-041655	Semaglutide	QSC	QSC-2511-M9226	PeptideMeter	2026-Q2	99.48	3.45	104.5	Supplier-supplied	1	MARGINAL
AX-2026-041362	Tirzepatide	WWB	WWB-2604-T3876	Janoshik	2026-Q2	99.93	4.40	—	Supplier-supplied	1	MARGINAL
AX-2026-041212	NAD+	WWB	WWB-2601-V1583	Janoshik	2026-Q2	99.93	10.36	88.5	Laboratory-retained	1	FAIL
AX-2026-042933	Semaglutide	MKM	MKM-2601-Y3343	Medutest	2026-Q2	98.25	3.50	—	Supplier-supplied	3	FAIL
AX-2026-042901	Semax	MKM	MKM-2512-B2992	Janoshik	2026-Q2	99.03	7.24	99.0	Supplier-supplied	1	MARGINAL
AX-2026-042727	Survodutide	GGPeps	GGPE-2512-Y9921	Nordanalyt	2026-Q2	97.45	3.38	—	Supplier-supplied	1	MARGINAL
AX-2026-042439	IGF-1 DES (1-3)	SWB	SWB-2601-Y5870	PeptideMeter	2026-Q2	97.76	3.79	—	Buyer-sourced	1	MARGINAL
AX-2026-042435	IGF-1 DES (1-3)	SWB	SWB-2601-Y5870	VendorInvestigate	2026-Q2	97.54	3.91	—	Buyer-sourced	1	MARGINAL
AX-2026-042339	L-Glutathione (reduced)	HJ	HJ-2511-F3082	Janoshik	2026-Q2	99.59	7.52	—	Laboratory-retained	0	PASS
AX-2026-042123	ARA-290	Homopeptide	HOMO-2601-T8238	Medutest	2026-Q2	99.93	3.40	102.7	Supplier-supplied	0	PASS
AX-2026-042122	ARA-290	Homopeptide	HOMO-2601-T8238	Nordanalyt	2026-Q2	99.57	3.74	90.6	Buyer-sourced	1	MARGINAL
AX-2026-041366	Semaglutide	WWB	WWB-2512-T3671	VendorInvestigate	2026-Q2	98.91	2.24	101.3	Buyer-sourced	2	MARGINAL
AX-2026-043523	MK-677 (Ibutamoren mesylate)	BCH	BCH-2511-G7276	Janoshik	2026-Q2	98.21	4.31	—	Supplier-supplied	1	FAIL
AX-2026-043342	TB-500	CPC	CPC-2605-B2433	Janoshik	2026-Q2	98.77	5.86	—	Supplier-supplied	3	MARGINAL
AX-2026-043269	Hexarelin	CPC	CPC-2511-F1491	Janoshik	2026-Q2	98.61	5.38	105.7	Supplier-supplied	2	FAIL
AX-2026-043236	Melanotan II	SGN	SGN-2602-L1809	Janoshik	2026-Q2	98.59	2.31	101.9	Supplier-supplied	0	PASS
AX-2026-042931	L-Glutathione (reduced)	MKM	MKM-2511-F2902	Janoshik	2026-Q2	99.29	8.88	100.4	Supplier-supplied	1	MARGINAL
AX-2026-042826	TB-500	GGPeps	GGPE-2605-J2051	VendorInvestigate	2026-Q2	99.19	5.07	—	Buyer-sourced	1	MARGINAL
AX-2026-042825	TB-500	GGPeps	GGPE-2605-J2051	PeptideMeter	2026-Q2	98.92	4.50	104.1	Buyer-sourced	1	MARGINAL
AX-2026-042760	TB-500	GGPeps	GGPE-2601-B9932	Nordanalyt	2026-Q2	99.05	4.21	—	Supplier-supplied	1	MARGINAL
AX-2026-042471	Semaglutide	SWB	SWB-2603-T5632	Janoshik	2026-Q2	98.53	6.58	—	Supplier-supplied	2	MARGINAL
AX-2026-041462	SS-31 (Elamipretide)	QYB	QYB-2512-H5402	Medutest	2026-Q2	98.98	4.73	98.6	Supplier-supplied	1	MARGINAL
AX-2026-043519	MGF	BCH	BCH-2511-D7240	Medutest	2026-Q2	98.87	6.14	—	Laboratory-retained	1	FAIL
AX-2026-042984	Desmopressin	KP	KP-2512-U5139	Janoshik	2026-Q2	99.09	2.79	93.8	Supplier-supplied	1	MARGINAL
AX-2026-042774	BPC-157	GGPeps	GGPE-2602-N9882	PeptideMeter	2026-Q2	98.94	5.45	100.2	Supplier-supplied	1	MARGINAL
AX-2026-042688	Retatrutide	GGPeps	GGPE-2604-U8733	PeptideMeter	2026-Q2	98.30	3.89	105.3	Supplier-supplied	2	MARGINAL
AX-2026-042266	Liraglutide	Homopeptide	HOMO-2602-E2761	Kestrel	2026-Q2	99.93	4.32	—	Supplier-supplied	0	PASS
AX-2026-042034	Gonadorelin	TFC	TFC-2511-E6450	Medutest	2026-Q2	99.81	2.67	—	Supplier-supplied	0	PASS
AX-2026-042032	Gonadorelin	TFC	TFC-2511-E6450	Janoshik	2026-Q2	99.62	3.09	—	Supplier-supplied	1	MARGINAL
AX-2026-041806	Tirzepatide	FGP	FGP-2605-R1831	Janoshik	2026-Q2	97.65	6.22	—	Supplier-supplied	2	MARGINAL